Peritumoral retraction clefting correlates with advanced stage squamous cell carcinoma of the esophagus

Pathology and Oncology Research

Volumn 14, Issue 4, 2008, Pages 443-447

  Bujas, Tatjana ^a   Pavić, Ivana ^b   Leniček, Tanja ^b   Mijić, August ^b   Krušlin, Božo ^b   Tomas, Davor ^b  

^a KARLOVAC GENERAL HOSPITAL   (Croatia)

^b SESTRE MILOSRDNICE UNIVERSITY HOSPITAL   (Croatia)

Author keywords

Esophagus; Metastases; Peritumoral clefting; Squamous cell carcinoma; Tumor stage

Indexed keywords

ADULT; ADVANCED CANCER; AGE DISTRIBUTION; AGED; ARTICLE; CANCER CLASSIFICATION; CANCER GRADING; CANCER INVASION; CANCER STAGING; CLINICAL ASSESSMENT; CLINICAL FEATURE; CONTROLLED STUDY; ESOPHAGEAL SQUAMOUS CELL CARCINOMA; FEMALE; HISTOPATHOLOGY; HUMAN; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; MORPHOLOGY; PATHOGENESIS; PERITUMORAL RETRACTION CLEFTING; SEX DIFFERENCE; TUMOR LOCALIZATION; TUMOR VOLUME;

EID: 60049086190     PISSN: 12194956     EISSN: None     Source Type: Journal    
DOI: 10.1007/s12253-008-9038-8     Document Type: Article

References (28)

1. Hashibe M, Boffetta P, Janout V et al (2007) Esophageal cancer in Central and Eastern Europe: tobacco and alcohol. Int J Cancer 120:1518-1522
2. Strnad M (ed) (2007) National Cancer Registry. Cancer incidence in Croatia 2005. Bulletin No. 30, Croatian National Institute of Public Health, Zagreb
3. Hamilton SR, Aaltonen LA (eds) (2001) WHO classification of tumours. Pathology and genetics of tumours of the digestive system. IARC, Lyon
4. Sleeman JP (2000) The lymph node as a bridgehead in the metastatic dissemination of tumors. Recent Results Cancer Res 157:55-81
5. Clarijs R, Ruiter DJ, de Waal RM (2001) Lymphangiogenesis in malignant tumours: does it occur? J Pathol 193:143-146
6. Tomas D, Kruslin B (2004) The potential value of (myo) fibroblastic stromal reaction in the diagnosis of prostatic adenocarcinoma. Prostate 61:324-331
7. Cheng MF, Tzao C, Tsai WC et al (2006) Expression of EMMPRJN and matriptase in esophageal squamous cell carcinoma: correlation with clinicopathological parameters. Dis Esophagus 19:482-486
8. Kruslin B, Tomas D, Rogatsch H et al (2003) Periacinar retraction clefting in the prostatic needle core biopsies: an important diagnostic criterion or a simple artifact? Virchows Arch 443:524-527
9. Bell KA, Smith Sehdev AE, Kurman RJ (2001) Refined diagnostic criteria for implants associated with ovarian atypical proliferative serous tumors (borderline) and micropapillary serous carcinomas. Am J Surg Pathol 25:419-423
10. Acs G, Dumoff KL, Solin LJ et al (2007) Extensive retraction artifact correlates with lymphatic invasion and nodal metastasis and predicts poor outcome in early stage breast carcinoma. Am J Surg Pathol 31:129-140
11. Irie J, Manucha V, Ioffe OB et al (2007) Artefact as the pathologist's friend: peritumoral retraction in in situ and infiltrating duct carcinoma of the breast. Int J Surg Pathol 15:53-59
12. Kruslin B, Tomas D, Rogatsch H et al (2005) Correlation of periacinar retraction clefting in needle core biopsies and corresponding prostatectomy specimens of patients with prostatic adenocarcinoma. Int J Surg Pathol 13:67-72
13. Ulamec M, Tomas D, Ensinger C et al (2007) Periacinar retraction clefting in proliferative prostatic atrophy and prostatic adenocar cinoma. J Clin Pathol 60:1098-1101
14. Sobin LH, Wittekind CH (eds) (2002) TNM classification of malignant tumors, 6th ed. Wiley-Liss, New York
15. Moore RD, Stevenson J, Schoenberg MD (1960) The response of connective tissue associated with tumors of the skin. Am J Clin Pathol 34:125-130
16. Halpert B, Sheehan EA, Schmalhorst WR et al (1963) Carcinoma of the prostate: a survey of 5000 autopsies. Cancer 16:736-742
17. Halpert B, Schmalhorst WR, Scott RJ (1966) Carcinoma of the prostate in patients 70 to 79 years old. Cancer 19:695-698
18. Mckenney JK, Gomez JA, Desai S et al (2001) Morphologic expressions of urothelial carcinoma in situ: a detailed evaluation of its histologic patterns with emphasis on carcinoma in situ with microinvasion. Am J Surg Pathol 25:356 - 362
19. Kruslin B, Tomas D, Cviko A et al (2006) Periacinar clefting and p63 immunostaining in prostatic intraepithelial neoplasia and prostatic carcinoma. Pathol Oncol Res 12:205-209
20. Tomas D, Ulamec M, Hudolin T et al (2006) Myofibroblastic stromal reaction and expression of tenascin-C and laminin in prostate adenocarcinoma. Prostate Cancer Prostatic Dis 9:414-419
21. Ishibashi S, Ohashi Y, Suzuki T et al (2006) Tumor-associated tissue eosinophilia in human esophageal squamous cell carcinoma. Anticancer Res 26:1419-1424
22. Guo SJ, Lin DM, Li J et al (2007) Tumor-associated macrophages and CD3-zeta expression of tumor-infiltrating lymphocytes in human esophageal squamous-cell carcinoma. Dis Esophagus 20:107-116
23. Nakanishi Y, Ochiai A, Kato H et al (2001) Clinicopathological significance of tumor nest configuration in patients with esophageal squamous cell carcinoma. Cancer 91:1114-1120
24. Nakayama Y, Matsumoto K, Nagato M et al (2007) Significance of lymphangiogenesis as assessed by immunohistochemistry for podoplanin in patients with esophageal carcinoma. Anticancer Res 27:619-625
25. Vallbohmer D, Lenz HJ (2006) Predictive and prognostic molecular markers in outcome of esophageal cancer. Dis Esophagus 19:425-432
26. Ingber DE (2002) Cancer as a disease of epithelial-mesenchymal interactions and extracellular matrix regulation. Differentiation 70:547-560
27. Wever DO, Mareel M (2003) Role of tissue tumor stroma in cancer cell invasion. J Pathol 200:429-447
28. Tomakidi P, Stark HJ, Herold-Mende C et al (2003) Discriminating expression of differentiation markers evolves in transplants of benign and malignant human skin keratinocytes through stromal interactions. J Pathol 200:298-307